scPharmaceuticals Inc.
SCPH
$2.56
-$0.01-0.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.32% | -105.41% | -21.14% | -2.14% | 11.65% |
| Total Depreciation and Amortization | 481.25% | -130.77% | 1.96% | -63.57% | -48.53% |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.40% | 435.38% | 381.43% | -19.77% | -182.50% |
| Change in Net Operating Assets | 103.80% | 33.26% | -160.46% | -381.75% | -170.16% |
| Cash from Operations | 12.84% | 13.86% | -14.27% | -16.78% | -12.69% |
| Capital Expenditure | -33.33% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | 10.64% | 215.59% |
| Cash from Investing | -33.33% | -1,000.00% | -100.00% | 10.79% | 215.43% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -99.68% | 18,837.81% | 56.35% | -61.24% | 586.76% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -104.00% | -- | -- | -- | -- |
| Cash from Financing | -100.90% | 24,780.92% | 1,786.67% | -96.79% | 586.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.88% | 365.66% | -271.43% | -1.18% | 132.42% |